Recent Finacing
Recent Raise
Bredis develops a patent‑protected ultra‑sensitive digital ELISA and AI analytics to detect blood biomarkers for Alzheimer’s, supporting early diagnosis, prognosis, and preparing IVD approvals and lab capacity in Korea.
Focus Areas
Recent Investors
Funding round
Investors